Fibroblast growth factor 10
| GO Term |
|---|
| extracellular space |
| nucleus |
| plasma membrane |
| collagen-containing extracellular matrix |
| cell surface |
| GO Term |
|---|
| heparin binding |
| type 2 fibroblast growth factor receptor binding |
| chemoattractant activity |
| growth factor activity |
| Pathway Name | Organism |
|---|---|
| Downstream signaling of activated FGFR1 | Mus musculus |
| FGFR1b ligand binding and activation | Mus musculus |
| FGFR2b ligand binding and activation | Mus musculus |
| FGFRL1 modulation of FGFR1 signaling | Mus musculus |
| FRS-mediated FGFR1 signaling | Mus musculus |
| FRS-mediated FGFR2 signaling | Mus musculus |
| Negative regulation of FGFR1 signaling | Mus musculus |
| Negative regulation of FGFR2 signaling | Mus musculus |
| PI-3K cascade:FGFR1 | Mus musculus |
| PI-3K cascade:FGFR2 | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050331 | lacrimoauriculodentodigital syndrome 1 | |
| DOID:10486 | intestinal atresia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025